|
University of California, Irvine |
Frank LaFerla |
SEED Grant |
Development of human ES cell lines as a model system for Alzheimer disease drug discovery |
$492,750 |
|
University of California, San Francisco |
Linda Giudice |
SEED Grant |
Human Embryonic Stem Cell Differentiation to Trophoblast: Basic Biology and Clinical Translation to Improve Human Fertility |
$640,399 |
|
University of California, San Francisco |
Su Guo |
SEED Grant |
Identifying small molecules that stimulate the differentiation of hESCs into dopamine-producing neurons |
$564,309 |
|
University of Southern California |
David Hinton |
SEED Grant |
Therapeutic potential of Retinal Pigment Epithelial cell lines derived from hES cells for retinal degeneration. |
$684,322 |
|
University of California, Irvine |
Michelle Khine |
SEED Grant |
Micro Platform for Controlled Cardiac Myocyte Differentiation |
$363,707 |
|
University of Southern California |
Wange Lu |
SEED Grant |
Regulation of human neural progenitor cell proliferation by Ryk-mediated Wnt signaling |
$668,987 |
|
Children's Hospital of Los Angeles |
Elizabeth Lawlor |
SEED Grant |
hESC as tools to investigate the neural crest origin of Ewing's sarcoma |
$675,001 |
|
University of California, San Diego |
Sylvia Evans |
SEED Grant |
Specification of Ventricular Myocyte and Pacemaker Lineages Utilizing Human Embryonic Stem Cells |
$609,999 |
|
University of California, Santa Cruz |
David Feldheim |
SEED Grant |
Assessing the role of Eph/ephrin signaling in hESC growth and differentiation |
$499,999 |
|
University of California, Los Angeles |
William Lowry |
SEED Grant |
Modeling Human Embryonic Development with Human Embryonic Stem Cells |
$571,575 |
|
Sanford-Burnham Medical Research Institute |
Ziwei Huang |
SEED Grant |
New Chemokine-Derived Therapeutics Targeting Stem Cell Migration |
$759,000 |
|
University of California, Los Angeles |
Siavash Kurdistani |
SEED Grant |
Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells |
$641,047 |
|
Stanford University |
Krishna Shenoy |
SEED Grant |
Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium |
$634,287 |
|
University of California, San Diego |
Catriona Jamieson |
SEED Grant |
Derivation and Characterization of Cancer Stem Cells from Human ES Cells |
$642,500 |
|
Stanford University |
Calvin Kuo |
SEED Grant |
Differentiation of Human Embryonic Stem Cells to Intestinal Fates |
$578,943 |
|
Stanford University |
Mark Kay |
SEED Grant |
Novel vectors for gene transfer into human ES cells |
$640,642 |
|
The J. David Gladstone Institutes |
Warner Greene |
SEED Grant |
The APOBEC3 Gene Family as Guardians of Genome Stability in Human Embryonic Stem Cells |
$777,467 |
|
University of California, Los Angeles |
Zoran Galic |
SEED Grant |
Genetic Enhancement of the Immune Response to Melanoma via hESC-derived T cells |
$642,501 |
|
University of California, San Diego |
Anirvan Ghosh |
SEED Grant |
Generation of forebrain neurons from human embryonic stem cells |
$612,075 |
|
Palo Alto Institute for Research and Education, Inc. |
Tony Wyss-Coray |
Basic Biology II |
Systemic Protein Factors as Modulators of the Aging Neurogenic Niche |
$1,522,800 |
|
University of California, Santa Cruz |
Bin Chen |
SEED Grant |
In vitro differentiation of hESCs into corticospinal motor neurons |
$500,000 |
|
Sanford-Burnham Medical Research Institute |
Huei-sheng Chen |
SEED Grant |
Development of Neuro-Coupled Human Embryonic Stem Cell-Derived Cardiac Pacemaker Cells. |
$744,639 |
|
Stanford University |
John Cooke |
SEED Grant |
EC regeneration in cerebrovascular ischemia: role of NO |
$658,125 |
|
University of California, San Diego |
Shu Chien |
SEED Grant |
Combinatorial Platform for Optimizing Microenvironments to Control hESC Fate |
$638,140 |
|
The Salk Institute for Biological Studies |
Senyon Choe |
SEED Grant |
A method to maintain and propagate pluripotent human ES cells |
$796,348 |
|
University of California, Irvine |
Marian Waterman |
Basic Biology II |
TCF-3: A Wnt Pathway Effector and Nanog Regulator in Pluripotent Stem Cell Self-Renewal |
$1,277,101 |
|
Sanford-Burnham Medical Research Institute |
Gregg Duester |
SEED Grant |
Retinoic Acid-FGF Antagonism during Motor Neuron Differentiation of Human ES Cells |
$759,000 |
|
University of California, San Diego |
Dong-Er Zhang |
Basic Biology II |
RUNX1 in maintenance, expansion, and differentiation of therapeutic pluripotent stem cells |
$1,371,540 |
|
iPierian, Inc. |
John Dimos |
Basic Biology II |
Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency |
$1,458,000 |
|
University of California, Los Angeles |
Irvin Chen |
SEED Grant |
Genetic modification of the human genome to resist HIV-1 infection and/or disease progression |
$642,652 |
|
University of California, San Francisco |
Robert Blelloch |
SEED Grant |
MicroRNA Regulation of Human Embryonic Stem Cell Self-Renewal and Differentiation |
$631,831 |
|
Buck Institute for Age Research |
Dale Bredesen |
SEED Grant |
Programmed Cell Death Pathways Activated in Embryonic Stem Cells |
$734,202 |
|
Human BioMolecular Research Institute |
John Cashman |
SEED Grant |
Discovering Potent Molecules with Human ESCs to Treat Heart Disease |
$714,654 |
|
University of California, Los Angeles |
Douglas Black |
Basic Biology II |
Programs of alternative splicing regulation by polypyrimidine tract binding protein |
$1,350,994 |
|
University of California, Los Angeles |
Yong Kim |
Basic Biology II |
Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells |
$1,259,371 |
|
Stanford University |
Steven Artandi |
Basic Biology II |
Self-renewal and senescence in iPS cells derived from patients with a stem cell disease |
$1,430,908 |
|
Sanford-Burnham Medical Research Institute |
Huei-sheng Chen |
Basic Biology II |
Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes |
$1,823,362 |
|
University of California, San Francisco |
John Rubenstein |
Basic Biology II |
MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells |
$1,387,800 |
|
Stanford University |
Garry Nolan |
Basic Biology II |
Kinase signaling analysis of iPS cell reprogramming and differentiation |
$1,447,956 |
|
University of California, Irvine |
Aileen Anderson |
Basic Biology II |
Role of the microenvironment in human iPS and NSC fate and tumorigenesis |
$1,284,921 |
|
University of California, San Diego |
Karl Willert |
Basic Biology I |
WNT signaling and the control of cell fate decisions in human pluripotent stem cells. |
$1,376,802 |
|
University of California, San Diego |
Kun-Liang Guan |
Basic Biology II |
The function of YAP in human embryonic stem cells |
$1,340,565 |
|
University of California, Los Angeles |
Robb Maclellan |
Basic Biology I |
Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate |
$1,378,076 |
|
University of California, Los Angeles |
Benhur Lee |
Basic Biology II |
The EphrinB2/EphB4 axis in regulating hESC pluripotency and differentiation |
$1,371,936 |
|
University of California, Davis |
Min Zhao |
Basic Biology I |
Directing migration of human stem cells with electric fields |
$1,052,715 |
|
Stanford University |
Aaron Hsueh |
Basic Biology II |
Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation |
$1,432,197 |
|
University of Southern California |
Wange Lu |
Basic Biology I |
Defining the molecular mechanisms of somatic cell reprogramming |
$1,468,360 |
|
The Salk Institute for Biological Studies |
Ronald Evans |
Basic Biology II |
Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs |
$1,712,880 |
|
University of California, Los Angeles |
Luisa Iruela-Arispe |
Basic Biology I |
Molecular Characterization and Functional Exploration of Hemogenic Endothelium |
$1,371,477 |
|
University of California, Los Angeles |
Bennett Novitch |
Basic Biology I |
Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons |
$1,363,262 |
|
University of California, Davis |
Eric Kurzrock |
Basic Biology II |
Differentiation of Human Embryonic Stem Cells into Urothelium |
$1,328,400 |
|
University of Southern California |
Martin Pera |
Basic Biology I |
The stem cell microenvironment in the maintenance of pluripotency and reprogramming |
$1,440,822 |
|
University of California, Los Angeles |
Michael Teitell |
Basic Biology I |
Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer |
$1,323,029 |
|
Stanford University |
Susan McConnell |
Basic Biology I |
Identification and characterization of human ES-derived DA neuronal subtypes |
$1,407,076 |
|
University of California, San Diego |
Eugene Yeo |
Basic Biology I |
RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency |
$1,376,802 |
|
Stanford University |
Julien Sage |
Basic Biology I |
The retinoblastoma (RB) gene family in cellular reprogramming |
$1,436,185 |
|
Stanford University |
Helen Blau |
Basic Biology I |
Molecular Mechanisms of Reprogramming towards Pluripotency |
$1,414,841 |
|
Western University of Health Sciences |
Douglas Ethell |
New Faculty I |
ES-Derived Cells for the Treatment of Alzheimer's Disease |
$2,120,833 |
|
The J. David Gladstone Institutes |
Sheng Ding |
New Faculty I |
Reprogramming of human somatic cells back to pluripotent embryonic stem cells |
$2,943,375 |
|
University of California, Santa Cruz |
Camilla Forsberg |
New Faculty I |
Mechanisms of Stem Cell Fate Decisions |
$2,330,111 |
|
University of California, San Diego |
Lawrence Goldstein |
Traning Grant I-1 |
Interdisciplinary Stem Cell Training Program at UCSD |
$3,684,349 |
|
University of California, Los Angeles |
Gay Crooks |
Transplantation Immunology |
Engineering Thymic Regeneration to Induce Tolerance |
$1,357,398 |
|
Stanford University |
Irving Weissman |
Tools and Technologies II |
Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs |
$1,869,487 |
|
University of California, San Diego |
Yang Xu |
Transplantation Immunology |
Induction of immune tolerance to human embryonic stem cell-derived allografts |
$1,193,292 |
|
University of California, Los Angeles |
Richard Gatti |
Tools and Technologies II |
Use of hiPSCs to develop lead compounds for the treatment of genetic diseases |
$1,833,054 |
|
University of California, Berkeley |
Irina Conboy |
New Faculty I |
Identification of hESC-mediated molecular mechanism that positively regulates the regenerative capacity of post-natal tissues |
$2,246,020 |
|
University of California, San Diego |
Karl Willert |
Tools and Technologies II |
Homologous recombination in human pluripotent stem cells using adeno-associated virus. |
$1,993,586 |
|
University of California, Irvine |
Frank LaFerla |
Early Translational I |
Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease |
$3,599,997 |
|
University of California, San Diego |
Yang Xu |
Early Translational I |
Developing induced pluripotent stem cells into human therapeutics and disease models |
$5,165,028 |
|
Scripps Research Institute |
Jeanne Loring |
Early Translational I |
Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation |
$6,292,290 |
|
Sanford-Burnham Medical Research Institute |
Mark Mercola |
Traning Grant I-2 |
Burnham Institute CIRM Stem Cell Training Grant (Type II) |
$1,489,640 |
|
Scripps Research Institute |
Jeanne Loring |
Transplantation Immunology |
Thymus based tolerance to stem cell therapies |
$1,269,844 |
|
Stanford University |
Anne Brunet |
New Faculty I |
Molecular mechanisms involved in adult neural stem cell maintenance |
$2,348,520 |
|
University of California, San Francisco |
Daniel Lim |
Tools and Technologies II |
Development and preclinical testing of new devices for cell transplantation to the brain. |
$1,831,723 |
|
University of California, San Francisco |
Tippi MacKenzie |
Transplantation Immunology |
Maternal and Fetal Immune Responses to In Utero Hematopoietic Stem Cell Transplantation |
$1,324,229 |
|
University of California, Berkeley |
David Raulet |
Transplantation Immunology |
Inactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue |
$958,808 |
|
Stanford University |
Michael Longaker |
Early Translational I |
Enhancing healing via Wnt-protein mediated activation of endogenous stem cells |
$5,767,050 |
|
Stanford University |
Kenneth Weinberg |
Transplantation Immunology |
“Engineered immune tolerance by Stem Cell-derived thymic regeneration” |
$1,415,836 |
|
University of California, Los Angeles |
Gabriel Travis |
Early Translational I |
Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration |
$5,503,069 |
|
University of California, San Diego |
Lawrence Goldstein |
Tools and Technologies II |
Developing a method for rapid identification of high-quality disease specific hIPSC lines |
$1,816,157 |
|
University of California, Santa Barbara |
Glenn Lucas |
Major Facilities |
No Title |
$3,205,800 |
|
The Parkinson's Institute |
Dennis Steindler |
Research Leadership 10 |
Stem Cell Pathologies in Parkinson’s disease as a key to Regenerative Strategies |
$6,718,471 |
|
Stanford University |
Robert Robbins |
Disease Team Planning |
{REDACTED} Cardiovascular Regenerative Team |
$55,000 |
|
University of California, Santa Cruz |
Margaret Delaney |
Major Facilities |
No Title |
$7,191,950 |
|
University of Southern California |
Andrew McMahon |
Research Leadership 10 |
Repair and regeneration of the nephron |
$5,672,206 |
|
University of California, Los Angeles |
Stanley Carmichael |
Disease Team Planning |
Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke |
$44,792 |
|
University of California, San Francisco |
Jeffrey Bluestone |
Disease Team Planning |
A CIRM Disease Team for the Treatment and Cure of Diabetes |
$55,000 |
|
University of California, San Francisco |
A. Washington |
Major Facilities |
No Title |
$34,862,400 |
|
University of Southern California |
David Woodley |
Disease Team Planning |
Clinical Regenerative Wound Healing With Stem Cells |
$42,574 |
|
University of Southern California |
Chrysostomos Nikias |
Major Facilities |
No Title |
$26,972,500 |
|
University of California, San Francisco |
Jeffrey Lotz |
Disease Team Planning |
A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage |
$55,000 |
|
University of Southern California |
Mark Humayun |
Disease Team Planning |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$50,001 |
|
The Salk Institute for Biological Studies |
Samuel Pfaff |
Disease Team Planning |
Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration |
$54,798 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Disease Team Planning |
Pluripotent Stem Cell–Based Therapy for Heart Disease |
$53,972 |
|
ViaCyte, Inc. |
Emmanuel Baetge |
Disease Team Planning |
Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes |
$48,950 |
|
Stanford University |
Thomas Rando |
Disease Team Planning |
Stem Cell Therapy for Muscular Dystrophy |
$52,650 |
|
University of California, San Diego |
Lawrence Goldstein |
Disease Team Planning |
Human Stem Cell Approaches to Alzheimers Disease Therapies |
$55,000 |
|
University of California, Los Angeles |
Irvin Chen |
Disease Team Planning |
Stem Cell Therapy for AIDS- Disease Team Planning |
$52,500 |
|
Buck Institute for Age Research |
Xianmin Zeng |
Disease Team Planning |
Develop a cell replacement therapy for Parkinson's disease using human embryonic stem cells |
$55,000 |
|
University of California, Irvine |
Henry Klassen |
Disease Team Planning |
Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa |
$37,367 |